PUMA BIOTECHNOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
PUMA BIOTECHNOLOGY, INC. (PBYI) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $4.02 per share as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2024-11-07
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $4.02.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $3.92.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $3.97.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $3.46.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price |
|---|---|
| 2024-09-30 | $4.02 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.92 10-Q · filed 2024-08-01 |
| 2024-03-31 | $3.97 10-Q · filed 2024-05-02 |
| 2023-12-31 | $3.46 10-Q · filed 2024-11-07 |
| 2023-09-30 | $3.52 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.55 10-Q · filed 2023-08-03 |
| 2023-03-31 | $3.62 10-Q · filed 2023-05-04 |
| 2022-12-31 | $4.25 10-K · filed 2024-02-29 |
| 2022-09-30 | $4.50 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.87 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.06 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.76 10-K · filed 2024-02-29 |
| 2021-09-30 | $7.85 10-Q · filed 2021-11-04 |
| 2021-06-30 | $8.11 10-Q · filed 2021-08-05 |
| 2021-03-31 | $8.42 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.71 10-K · filed 2023-03-02 |
| 2020-09-30 | $9.42 10-Q · filed 2020-11-05 |
| 2020-06-30 | $10.57 10-Q · filed 2020-08-06 |
| 2020-03-31 | $11.47 10-Q · filed 2020-05-07 |
| 2019-12-31 | $19.38 10-K · filed 2022-03-03 |
| 2019-09-30 | $29.85 10-Q · filed 2019-11-07 |
| 2019-06-30 | $30.25 10-Q · filed 2019-08-09 |
| 2019-03-31 | $30.31 10-Q · filed 2019-05-10 |
| 2018-12-31 | $33.75 10-K · filed 2021-03-01 |
| 2018-09-30 | $34.49 10-Q · filed 2018-11-05 |
| 2018-06-30 | $34.42 10-Q · filed 2018-08-09 |
| 2018-03-31 | $35.34 10-Q · filed 2018-05-10 |
| 2017-12-31 | $33.37 10-K · filed 2020-02-28 |
| 2017-09-30 | $35.31 10-Q · filed 2017-11-09 |
| 2017-06-30 | $39.16 10-Q · filed 2017-08-09 |
| 2017-03-31 | $41.50 10-Q · filed 2017-05-10 |
| 2016-12-31 | $47.78 10-K · filed 2019-03-01 |
| 2016-09-30 | $59.27 10-Q · filed 2016-11-09 |
| 2016-06-30 | $63.20 10-Q · filed 2016-08-09 |
| 2016-03-31 | $70.72 10-Q · filed 2016-05-10 |
| 2015-12-31 | $73.59 10-K · filed 2018-03-09 |
| 2015-09-30 | $90.95 10-Q · filed 2015-11-09 |
| 2015-06-30 | $97.49 10-Q · filed 2015-08-10 |
| 2015-03-31 | $90.53 10-Q · filed 2015-05-11 |
| 2014-12-31 | $81.33 10-K · filed 2016-02-29 |
| 2013-12-31 | $20.18 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |